Panchasutra Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 1.00 M
as on 22-06-2024
- Paid Up Capital ₹ 0.22 M
as on 22-06-2024
- Company Age 9 Year, 6 Months
- Last Filing with ROC 31 Mar 2019
- Revenue %
(FY 2019)
- Profit -759.28%
(FY 2019)
- Ebitda -895.98%
(FY 2019)
- Net Worth 502.04%
(FY 2019)
- Total Assets 13064.53%
(FY 2019)
About Panchasutra Lifesciences
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2019. It's a company limited by shares with an authorized capital of Rs 1.00 M and a paid-up capital of Rs 0.22 M, as per Ministry of Corporate Affairs (MCA) records.
Bhaswati Bhattacharya, Gayathri Kadkol, and Satyajith Kadkol serve as directors at the Company.
- CIN/LLPIN
U85110KA2015PTC080953
- Company No.
080953
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
17 Jun 2015
- Date of AGM
04 Sep 2019
- Date of Balance Sheet
31 Mar 2019
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Udupi, Karnataka, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Panchasutra Lifesciences?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Satyajith Kadkol  | Additional Director | 17-Jun-2015 | Current |
| Bhaswati Bhattacharya | Additional Director | 17-Oct-2020 | Current |
| Gayathri Kadkol | Additional Director | 17-Jun-2015 | Current |
Financial Performance of Panchasutra Lifesciences.
Panchasutra Lifesciences Private Limited, for the financial year ended 2019, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 759.28% decrease in profit. The company's net worth Soared by an impressive increase of 502.04%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Panchasutra Lifesciences?
In 2018, Panchasutra Lifesciences had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vritti Ayush Collaborative Private LimitedActive 4 years 3 monthsBhaswati Bhattacharya and Satyajith Kadkol are mutual person
- Result Consultancy Services Private LimitedActive 5 years 3 months
Satyajith Kadkol is a mutual person
- Vaanaprastha Lifetime Spaces Private LimitedActive 9 years 4 months
Satyajith Kadkol is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Panchasutra Lifesciences?
Unlock and access historical data on people associated with Panchasutra Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Panchasutra Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Panchasutra Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
